136742-83-1

Basic information

• Product Name: 1H-Pyrido[2,3-b][1,4]oxazin-2(3H)-one(9CI)
• Synonyms: 1H-Pyrido[2,3-b][1,4]oxazin-2(3H)-one(9CI);1H,2H,3H-pyrido[2,3-b][1,4]oxazin-2-one
• CAS NO: 136742-83-1
• Molecular Formula: C7H6N2O2
• Molecular Weight: 150.14
• Product Categories: PYRIDINE
• Mol File: 136742-83-1.mol

Chemical Properties

• Boiling Point: 384.2±37.0 °C(Predicted)
• Appearance: /
• Density: 1.327±0.06 g/cm3(Predicted)
• PKA: 11.55±0.20(Predicted)
• CAS DataBase Reference: 1H-Pyrido[2,3-b][1,4]oxazin-2(3H)-one(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrido[2,3-b][1,4]oxazin-2(3H)-one(9CI)(136742-83-1)
• EPA Substance Registry System: 1H-Pyrido[2,3-b][1,4]oxazin-2(3H)-one(9CI)(136742-83-1)

Safety Data

• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 136742-83-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research:
1H-Pyrido[2,3-b][1,4]oxazin-2(3H)-one(9CI) is used as a key intermediate in the synthesis of various pharmaceutical compounds for its unique heterocyclic structure. Its ability to form stable complexes and its potential biological activity make it a promising candidate for drug development.
Used in Materials Science:
In the field of materials science, 1H-Pyrido[2,3-b][1,4]oxazin-2(3H)-one(9CI) is utilized as a component in the development of novel materials with specific properties. Its incorporation into polymers or other materials can enhance their stability, reactivity, or other desired characteristics.
Used in Chemical Synthesis:
1H-Pyrido[2,3-b][1,4]oxazin-2(3H)-one(9CI) serves as a versatile building block in organic synthesis, allowing for the creation of a wide range of chemical entities. Its reactivity and structural features facilitate its use in the synthesis of complex organic molecules for various applications.
Used in Analytical Chemistry:
As a compound with distinct spectroscopic properties, 1H-Pyrido[2,3-b][1,4]oxazin-2(3H)-one(9CI) can be employed as a reference material or analytical standard in various analytical techniques, such as chromatography, mass spectrometry, and nuclear magnetic resonance (NMR) spectroscopy.

Upstream product

• 33630-99-8 2-hydroxy-3-aminopyridine 
• 79-04-9 chloroacetyl chloride 
• 353292-97-4 (3-amino-pyridin-2-yloxy)-acetic acid methyl ester 
• 6636-78-8 2-chloro-3-hydroxypyridine 
• 79-07-2 Chloroacetamide 

Downstream Products

• 1112193-37-9 2,3-Dihydro-1H-4-oxa-1,5-diaza-naphthalene 

Relevant articles and documents

Microwave-assisted synthesis of benzo-[1,4]-oxazinones using MeO-PEG-OMe as solvent

Efficient one-pot microwave-assisted synthesis of various benzo-[1,4]-oxazinones via Smiles rearrangement is described. Treatment of 2-chloroacetamide, substituted 2-chlorophenols and cesium carbonate in MeO-PEG-OMe (2,000) as solvent afforded the corresp

HETEROCYCLIC DERIVATIVES

The present invention relates to heterocyclic derivatives, and more particularly, to novel heterocyclic derivatives useful for the preparation of medicaments for treating diseases related to uric acid.

EP2/4 AGONISTS

EP2/4 compounds having improved dual pharmacological activity are described. The uniqueness of using EP2/4 dual agonists resides in their ability to modify both uveoscleral outflow via the ciliary muscle and conventional outflow via trabecular meshwork and Schlemm's canal all in the same treatment paradigm. The compounds can be employed for the treatment of glaucoma and ocular hypertension. Formula (I).

Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazines

The SAR and pharmacokinetic profiles of a series of multi-isoform PI3K inhibitors based on a 3,4-dihydro-2H-benzo[1,4]oxazine scaffold are disclosed.